Cargando…
Inhibition of menin, BCL-2, and FLT3 combined with a hypomethylating agent cures NPM1/FLT3-ITD/-TKD mutant acute myeloid leukemia in a patient-derived xenograft model
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483344/ https://www.ncbi.nlm.nih.gov/pubmed/36727398 http://dx.doi.org/10.3324/haematol.2022.281927 |
| _version_ | 1785102354818793472 |
|---|---|
| author | Carter, Bing Z. Mak, Po Yee Tao, Wenjing Ostermann, Lauren B. Mak, Duncan H. Ke, Baozhen Ordentlich, Peter McGeehan, Gerard M. Andreeff, Michael |
| author_facet | Carter, Bing Z. Mak, Po Yee Tao, Wenjing Ostermann, Lauren B. Mak, Duncan H. Ke, Baozhen Ordentlich, Peter McGeehan, Gerard M. Andreeff, Michael |
| author_sort | Carter, Bing Z. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10483344 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104833442023-09-08 Inhibition of menin, BCL-2, and FLT3 combined with a hypomethylating agent cures NPM1/FLT3-ITD/-TKD mutant acute myeloid leukemia in a patient-derived xenograft model Carter, Bing Z. Mak, Po Yee Tao, Wenjing Ostermann, Lauren B. Mak, Duncan H. Ke, Baozhen Ordentlich, Peter McGeehan, Gerard M. Andreeff, Michael Haematologica Letter to the Editor Fondazione Ferrata Storti 2023-02-02 /pmc/articles/PMC10483344/ /pubmed/36727398 http://dx.doi.org/10.3324/haematol.2022.281927 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Carter, Bing Z. Mak, Po Yee Tao, Wenjing Ostermann, Lauren B. Mak, Duncan H. Ke, Baozhen Ordentlich, Peter McGeehan, Gerard M. Andreeff, Michael Inhibition of menin, BCL-2, and FLT3 combined with a hypomethylating agent cures NPM1/FLT3-ITD/-TKD mutant acute myeloid leukemia in a patient-derived xenograft model |
| title | Inhibition of menin, BCL-2, and FLT3 combined with a hypomethylating agent cures NPM1/FLT3-ITD/-TKD mutant acute myeloid leukemia in a patient-derived xenograft model |
| title_full | Inhibition of menin, BCL-2, and FLT3 combined with a hypomethylating agent cures NPM1/FLT3-ITD/-TKD mutant acute myeloid leukemia in a patient-derived xenograft model |
| title_fullStr | Inhibition of menin, BCL-2, and FLT3 combined with a hypomethylating agent cures NPM1/FLT3-ITD/-TKD mutant acute myeloid leukemia in a patient-derived xenograft model |
| title_full_unstemmed | Inhibition of menin, BCL-2, and FLT3 combined with a hypomethylating agent cures NPM1/FLT3-ITD/-TKD mutant acute myeloid leukemia in a patient-derived xenograft model |
| title_short | Inhibition of menin, BCL-2, and FLT3 combined with a hypomethylating agent cures NPM1/FLT3-ITD/-TKD mutant acute myeloid leukemia in a patient-derived xenograft model |
| title_sort | inhibition of menin, bcl-2, and flt3 combined with a hypomethylating agent cures npm1/flt3-itd/-tkd mutant acute myeloid leukemia in a patient-derived xenograft model |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483344/ https://www.ncbi.nlm.nih.gov/pubmed/36727398 http://dx.doi.org/10.3324/haematol.2022.281927 |
| work_keys_str_mv | AT carterbingz inhibitionofmeninbcl2andflt3combinedwithahypomethylatingagentcuresnpm1flt3itdtkdmutantacutemyeloidleukemiainapatientderivedxenograftmodel AT makpoyee inhibitionofmeninbcl2andflt3combinedwithahypomethylatingagentcuresnpm1flt3itdtkdmutantacutemyeloidleukemiainapatientderivedxenograftmodel AT taowenjing inhibitionofmeninbcl2andflt3combinedwithahypomethylatingagentcuresnpm1flt3itdtkdmutantacutemyeloidleukemiainapatientderivedxenograftmodel AT ostermannlaurenb inhibitionofmeninbcl2andflt3combinedwithahypomethylatingagentcuresnpm1flt3itdtkdmutantacutemyeloidleukemiainapatientderivedxenograftmodel AT makduncanh inhibitionofmeninbcl2andflt3combinedwithahypomethylatingagentcuresnpm1flt3itdtkdmutantacutemyeloidleukemiainapatientderivedxenograftmodel AT kebaozhen inhibitionofmeninbcl2andflt3combinedwithahypomethylatingagentcuresnpm1flt3itdtkdmutantacutemyeloidleukemiainapatientderivedxenograftmodel AT ordentlichpeter inhibitionofmeninbcl2andflt3combinedwithahypomethylatingagentcuresnpm1flt3itdtkdmutantacutemyeloidleukemiainapatientderivedxenograftmodel AT mcgeehangerardm inhibitionofmeninbcl2andflt3combinedwithahypomethylatingagentcuresnpm1flt3itdtkdmutantacutemyeloidleukemiainapatientderivedxenograftmodel AT andreeffmichael inhibitionofmeninbcl2andflt3combinedwithahypomethylatingagentcuresnpm1flt3itdtkdmutantacutemyeloidleukemiainapatientderivedxenograftmodel |